Griffin Asset Management Inc increased its stake in Bristol Myers Squibb (BMY) by 4.65% based on its latest 2017Q4 regulatory filing with the SEC. Griffin Asset Management Inc bought 8,230 shares as the company’s stock rose 2.38% while stock markets declined. The institutional investor held 185,153 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $11.35M, up from 176,923 at the end of the previous reported quarter. Griffin Asset Management Inc who had been investing in Bristol Myers Squibb for a number of months, seems to be bullish on the $85.36 billion market cap company. The stock decreased 0.17% or $0.09 during the last trading session, reaching $52.21. About 5.42 million shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has risen 11.37% since May 17, 2017 and is uptrending. It has underperformed by 0.18% the S&P500.
Benedict Financial Advisors Inc decreased its stake in Microsoft Corp (MSFT) by 3.95% based on its latest 2017Q4 regulatory filing with the SEC. Benedict Financial Advisors Inc sold 4,258 shares as the company’s stock rose 4.63% while stock markets declined. The institutional investor held 103,665 shares of the prepackaged software company at the end of 2017Q4, valued at $8.87 million, down from 107,923 at the end of the previous reported quarter. Benedict Financial Advisors Inc who had been investing in Microsoft Corp for a number of months, seems to be less bullish one the $746.42B market cap company. The stock increased 0.26% or $0.25 during the last trading session, reaching $97.15. About 14.51M shares traded. Microsoft Corporation (NASDAQ:MSFT) has risen 37.43% since May 17, 2017 and is uptrending. It has outperformed by 25.88% the S&P500.
Investors sentiment decreased to 0.94 in Q4 2017. Its down 0.09, from 1.03 in 2017Q3. It dived, as 72 investors sold BMY shares while 526 reduced holdings. 106 funds opened positions while 457 raised stakes. 1.11 billion shares or 0.48% more from 1.11 billion shares in 2017Q3 were reported. Baker Ellis Asset Management Ltd Llc owns 33,202 shares. North Management Corporation reported 10,400 shares. Meeder Asset Inc owns 59,503 shares. Whittier Trust holds 0.38% or 175,602 shares. Elm Advsrs Ltd Co stated it has 6,583 shares. New England Research & Mngmt stated it has 22,667 shares. Proshare Advsrs Limited Liability Corp has 319,538 shares. Rothschild Asset Management Inc holds 0% or 6,036 shares. Opus Invest invested 0.48% in Bristol-Myers Squibb Company (NYSE:BMY). Camarda Advsr Ltd Company reported 21,631 shares or 1.59% of all its holdings. Boston Family Office Limited Liability Corporation holds 0.28% or 42,352 shares. Sawgrass Asset Management Limited Liability reported 32,975 shares. Osborne Cap Management Limited Liability Corp holds 0.86% or 105,792 shares in its portfolio. Private Na has 0.8% invested in Bristol-Myers Squibb Company (NYSE:BMY). Pictet Asset Ltd stated it has 0.27% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY).
Griffin Asset Management Inc, which manages about $394.93M and $561.95M US Long portfolio, decreased its stake in Us Bancorp (NYSE:USB) by 7,404 shares to 61,546 shares, valued at $3.30 million in 2017Q4, according to the filing. It also reduced its holding in Sysco Corp (NYSE:SYY) by 9,597 shares in the quarter, leaving it with 49,866 shares, and cut its stake in Novartis Ag Adr (NYSE:NVS).
Since December 12, 2017, it had 2 buys, and 1 insider sale for $163,963 activity. 4,770 shares were bought by Paliwal Dinesh C, worth $249,948. 4,000 shares were bought by Samuels Theodore R. II, worth $249,187.
Among 22 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 2 Sell and 13 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 86 analyst reports since July 28, 2015 according to SRatingsIntel. As per Friday, April 13, the company rating was maintained by Jefferies. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Underweight” rating by Piper Jaffray on Monday, August 24. The rating was maintained by Barclays Capital on Tuesday, December 1 with “Equal Weight”. BMO Capital Markets maintained Bristol-Myers Squibb Company (NYSE:BMY) on Sunday, July 23 with “Sell” rating. The company was downgraded on Friday, August 5 by Morgan Stanley. Guggenheim maintained it with “Buy” rating and $7200 target in Tuesday, April 17 report. Leerink Swann maintained the stock with “Outperform” rating in Monday, October 23 report. The company was maintained on Thursday, October 19 by Cowen & Co. Atlantic Securities initiated Bristol-Myers Squibb Company (NYSE:BMY) rating on Friday, December 18. Atlantic Securities has “Underweight” rating and $57 target. The firm has “Buy” rating given on Wednesday, October 18 by Citigroup.
More notable recent Bristol-Myers Squibb Company (NYSE:BMY) news were published by: Seekingalpha.com which released: “Ziopharm, Trump’s Drug Pricing Plan And The Future Of Expensive Drug Development” on May 15, 2018, also Bizjournals.com with their article: “How Bristol-Myers Squibb’s new Peninsula digs boost its battle to beat cancer” published on May 01, 2018, Fool.com published: “Why Bristol-Myers Squibb Stock Crashed in April” on May 09, 2018. More interesting news about Bristol-Myers Squibb Company (NYSE:BMY) were released by: Streetinsider.com and their article: “Bristol-Myers Squibb (BMY) Highlights Breadth of Immuno-Oncologyâ€“Based Combination Research and Commitment …” published on May 16, 2018 as well as Seekingalpha.com‘s news article titled: “Don’t Buy L Brands – Cramer’s Lightning Round (5/15/18)” with publication date: May 16, 2018.
Analysts await Microsoft Corporation (NASDAQ:MSFT) to report earnings on July, 19. They expect $1.08 earnings per share, up 10.20% or $0.10 from last year’s $0.98 per share. MSFT’s profit will be $8.30 billion for 22.49 P/E if the $1.08 EPS becomes a reality. After $0.95 actual earnings per share reported by Microsoft Corporation for the previous quarter, Wall Street now forecasts 13.68% EPS growth.
Investors sentiment decreased to 0.77 in 2017 Q4. Its down 0.06, from 0.83 in 2017Q3. It dived, as 39 investors sold MSFT shares while 1012 reduced holdings. 134 funds opened positions while 676 raised stakes. 5.46 billion shares or 0.90% less from 5.51 billion shares in 2017Q3 were reported. Ardevora Asset Ltd Liability Partnership accumulated 354,800 shares. Security State Bank Of Sioux City Iowa Ia invested 1.99% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). Vaughan Nelson Inv Mngmt LP has invested 1.24% in Microsoft Corporation (NASDAQ:MSFT). Gabalex Capital Management Ltd Liability Corporation invested in 3.69% or 150,000 shares. Private Wealth Advisors reported 39,764 shares. Lbmc Inv Advsrs Ltd Liability Co has invested 0.09% in Microsoft Corporation (NASDAQ:MSFT). Artemis Inv Ltd Liability Partnership reported 702,348 shares. Psagot Inv House Limited accumulated 5,500 shares or 0.02% of the stock. 13,321 are owned by Driehaus Management Ltd Limited Liability Company. Fayerweather Charles holds 13,381 shares or 1.67% of its portfolio. Victory Mgmt has 1.08M shares. 250,937 were accumulated by Interocean Limited Liability Com. 33,732 are held by Clear Harbor Asset Mngmt Ltd Liability. Kayne Anderson Rudnick Inv Mgmt Ltd Co holds 0.01% or 12,024 shares in its portfolio. 145,858 were accumulated by Guardian Capital Advisors Limited Partnership.
Among 37 analysts covering Microsoft Corporation (NASDAQ:MSFT), 31 have Buy rating, 1 Sell and 5 Hold. Therefore 84% are positive. Microsoft Corporation had 183 analyst reports since July 22, 2015 according to SRatingsIntel. As per Monday, October 2, the company rating was maintained by Piper Jaffray. Evercore maintained Microsoft Corporation (NASDAQ:MSFT) on Friday, December 8 with “Buy” rating. J.P. Morgan maintained the shares of MSFT in report on Thursday, January 25 with “Hold” rating. The stock of Microsoft Corporation (NASDAQ:MSFT) earned “Buy” rating by Stifel Nicolaus on Monday, August 21. On Monday, August 7 the stock rating was maintained by Credit Suisse with “Buy”. Credit Suisse maintained Microsoft Corporation (NASDAQ:MSFT) on Tuesday, September 26 with “Buy” rating. The firm earned “Buy” rating on Tuesday, July 18 by Goldman Sachs. The firm has “Outperform” rating given on Friday, January 27 by RBC Capital Markets. As per Tuesday, August 22, the company rating was maintained by Credit Suisse. Cowen & Co maintained it with “Market Perform” rating and $59 target in Friday, April 1 report.
More notable recent Microsoft Corporation (NASDAQ:MSFT) news were published by: Nasdaq.com which released: “Microsoft Corporation Replacing Surface Pro 4s in â€œFlickergateâ€ Resolution” on May 14, 2018, also 247Wallst.com with their article: “How Microsoft Went From Acquirer to Partner” published on April 19, 2018, 247Wallst.com published: “Microsoft Catches Amazon as Second Most Valuable Company” on April 25, 2018. More interesting news about Microsoft Corporation (NASDAQ:MSFT) were released by: Seekingalpha.com and their article: “Microsoft Does It Again” published on May 01, 2018 as well as 247Wallst.com‘s news article titled: “Will Microsoft’s Q1 Earnings Boost Its Valuation?” with publication date: April 26, 2018.
Since February 16, 2018, it had 0 insider purchases, and 3 selling transactions for $930,912 activity.